Advanced Biomed Inc.
ADVB
$0.71
$0.074211.67%
NASDAQ
03/31/2025 | 12/31/2024 | 03/31/2024 | |||
---|---|---|---|---|---|
Net Income | -52.43% | -241.83% | -626.91% | ||
Total Depreciation and Amortization | -21.19% | -3.03% | 13.08% | ||
Total Amortization of Deferred Charges | -- | -- | -- | ||
Total Other Non-Cash Items | -- | -- | -- | ||
Change in Net Operating Assets | -6,275.15% | -124.68% | -186.92% | ||
Cash from Operations | -305.04% | -2,734.34% | -3,207.00% | ||
Capital Expenditure | -120.56% | 153.50% | 156.09% | ||
Sale of Property, Plant, and Equipment | -- | -- | -- | ||
Cash Acquisitions | -- | -- | -- | ||
Divestitures | -- | -- | -- | ||
Other Investing Activities | -- | -- | -- | ||
Cash from Investing | -120.56% | 153.50% | 156.09% | ||
Total Debt Issued | -38.13% | 3.86% | -24.65% | ||
Total Debt Repaid | -- | -- | -- | ||
Issuance of Common Stock | -- | -- | -- | ||
Repurchase of Common Stock | -- | -- | -- | ||
Issuance of Preferred Stock | -- | -- | -- | ||
Repurchase of Preferred Stock | -- | -- | -- | ||
Total Dividends Paid | -- | -- | -- | ||
Other Financing Activities | 33,647.62% | 0.00% | 200.00% | ||
Cash from Financing | 1,344.77% | 4.03% | -15.83% | ||
Foreign Exchange rate Adjustments | -90.83% | 242.56% | 178.20% | ||
Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
Net Change in Cash | 24,673.53% | -73.85% | -159.61% | ||